The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia

Yi Xu, Takita Felder Sumter, Raka Bhattacharya, Abeba Tesfaye, Ephraim J. Fuchs, Lisa Wood, David L. Huso, Linda M S Resar

    Research output: Contribution to journalArticle

    96 Citations (Scopus)

    Abstract

    HMG-I/Y is overexpressed in human cancer, although a direct role for this gene in transformation has not been established. We generated transgenic mice with HMG-I targeted to lymphoid cells. All seven informative founder HMG-I mice developed aggressive lymphoma by a mean age of 4.8 months. Tumors express T-cell markers and are transplantable. We also demonstrate that HMG-I mRNA and protein are increased in human acute lymphocytic leukemia samples. Our results show that HMG-I functions as an oncogene and suggest that it contributes to the pathogenesis of leukemia and other cancers with increased HMG-I expression.

    Original languageEnglish (US)
    Pages (from-to)3371-3375
    Number of pages5
    JournalCancer Research
    Volume64
    Issue number10
    DOIs
    StatePublished - May 15 2004

    Fingerprint

    Oncogenes
    Transgenic Mice
    Leukemia
    Neoplasms
    Precursor Cell Lymphoblastic Leukemia-Lymphoma
    Lymphoma
    Lymphocytes
    T-Lymphocytes
    Messenger RNA
    Genes
    Proteins

    ASJC Scopus subject areas

    • Cancer Research
    • Oncology

    Cite this

    Xu, Y., Sumter, T. F., Bhattacharya, R., Tesfaye, A., Fuchs, E. J., Wood, L., ... Resar, L. M. S. (2004). The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Research, 64(10), 3371-3375. https://doi.org/10.1158/0008-5472.CAN-04-0044

    The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. / Xu, Yi; Sumter, Takita Felder; Bhattacharya, Raka; Tesfaye, Abeba; Fuchs, Ephraim J.; Wood, Lisa; Huso, David L.; Resar, Linda M S.

    In: Cancer Research, Vol. 64, No. 10, 15.05.2004, p. 3371-3375.

    Research output: Contribution to journalArticle

    Xu, Y, Sumter, TF, Bhattacharya, R, Tesfaye, A, Fuchs, EJ, Wood, L, Huso, DL & Resar, LMS 2004, 'The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia', Cancer Research, vol. 64, no. 10, pp. 3371-3375. https://doi.org/10.1158/0008-5472.CAN-04-0044
    Xu, Yi ; Sumter, Takita Felder ; Bhattacharya, Raka ; Tesfaye, Abeba ; Fuchs, Ephraim J. ; Wood, Lisa ; Huso, David L. ; Resar, Linda M S. / The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. In: Cancer Research. 2004 ; Vol. 64, No. 10. pp. 3371-3375.
    @article{43aa3256e8d840b49d361bcc6e5a7f35,
    title = "The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia",
    abstract = "HMG-I/Y is overexpressed in human cancer, although a direct role for this gene in transformation has not been established. We generated transgenic mice with HMG-I targeted to lymphoid cells. All seven informative founder HMG-I mice developed aggressive lymphoma by a mean age of 4.8 months. Tumors express T-cell markers and are transplantable. We also demonstrate that HMG-I mRNA and protein are increased in human acute lymphocytic leukemia samples. Our results show that HMG-I functions as an oncogene and suggest that it contributes to the pathogenesis of leukemia and other cancers with increased HMG-I expression.",
    author = "Yi Xu and Sumter, {Takita Felder} and Raka Bhattacharya and Abeba Tesfaye and Fuchs, {Ephraim J.} and Lisa Wood and Huso, {David L.} and Resar, {Linda M S}",
    year = "2004",
    month = "5",
    day = "15",
    doi = "10.1158/0008-5472.CAN-04-0044",
    language = "English (US)",
    volume = "64",
    pages = "3371--3375",
    journal = "Journal of Cancer Research",
    issn = "0099-7013",
    publisher = "American Association for Cancer Research Inc.",
    number = "10",

    }

    TY - JOUR

    T1 - The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia

    AU - Xu, Yi

    AU - Sumter, Takita Felder

    AU - Bhattacharya, Raka

    AU - Tesfaye, Abeba

    AU - Fuchs, Ephraim J.

    AU - Wood, Lisa

    AU - Huso, David L.

    AU - Resar, Linda M S

    PY - 2004/5/15

    Y1 - 2004/5/15

    N2 - HMG-I/Y is overexpressed in human cancer, although a direct role for this gene in transformation has not been established. We generated transgenic mice with HMG-I targeted to lymphoid cells. All seven informative founder HMG-I mice developed aggressive lymphoma by a mean age of 4.8 months. Tumors express T-cell markers and are transplantable. We also demonstrate that HMG-I mRNA and protein are increased in human acute lymphocytic leukemia samples. Our results show that HMG-I functions as an oncogene and suggest that it contributes to the pathogenesis of leukemia and other cancers with increased HMG-I expression.

    AB - HMG-I/Y is overexpressed in human cancer, although a direct role for this gene in transformation has not been established. We generated transgenic mice with HMG-I targeted to lymphoid cells. All seven informative founder HMG-I mice developed aggressive lymphoma by a mean age of 4.8 months. Tumors express T-cell markers and are transplantable. We also demonstrate that HMG-I mRNA and protein are increased in human acute lymphocytic leukemia samples. Our results show that HMG-I functions as an oncogene and suggest that it contributes to the pathogenesis of leukemia and other cancers with increased HMG-I expression.

    UR - http://www.scopus.com/inward/record.url?scp=2442668067&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=2442668067&partnerID=8YFLogxK

    U2 - 10.1158/0008-5472.CAN-04-0044

    DO - 10.1158/0008-5472.CAN-04-0044

    M3 - Article

    VL - 64

    SP - 3371

    EP - 3375

    JO - Journal of Cancer Research

    JF - Journal of Cancer Research

    SN - 0099-7013

    IS - 10

    ER -